16, 519–534. https://doi.org/10.2147/NDT.S225643. ... 2.0), 25zf0127010h0001 (AMED Moonshot). 10.1093/schizbullopen/sgad001. ... schizophrenia spectrum disorders: ...
https://t.co/90AhYXu5Rk
Mentions
Extended reach
Total likes
Video views
AI synopsis
Many discussions highlight the significance of recognizing atypical presentations of negative symptoms, with phrases like 'key to early diagnosis' and 'treatment challenges' indicating recognition of clinical impact. The tone varies from informative to reflective, exemplified by comments on the resistance of primary negative symptoms to treatments, illustrating an understanding of the article's importance in advancing clinical awareness.
Most discussions acknowledge the relevance of the review, with praise for its comprehensive coverage of negative symptoms and acknowledgment of its utility in clinical settings.
Participants display moderate interest, discussing specific symptoms like avolition and asociality, but some show limited curiosity beyond basic recognition.
Comments reflect some thoughtful analysis, such as critiques of treatment resistance, but a few posts merely acknowledge the publication without deeper interaction.
The overall influence appears moderate, with some posts indicating that the publication may inform clinical approaches, yet few mention potential shifts in practice or policy.
https://t.co/90AhYXu5Rk
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment https://t.co/Kajnd0erK5
Negative symptoms, common in schizophrenia and schizoaffective disorder, include avolition and asociality. This video shares personal experience with these symptoms and their impact, highlighting the importance of…
Negative symptoms of schizophrenia are often misunderstood, appearing as subtle changes like loss of motivation, reduced pleasure, and social withdrawal. This video explores these symptoms, their causes, and treatment…
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment https://t.co/Kajnd0erK5
https://t.co/90AhYXu5Rk
16, 519–534. https://doi.org/10.2147/NDT.S225643. ... 2.0), 25zf0127010h0001 (AMED Moonshot). 10.1093/schizbullopen/sgad001. ... schizophrenia spectrum disorders: ...
Guide for Recognition, Assessment, and Treatment. Neuropsychiatr Dis Treat. 2020;16,519-534. Published Feb 21. doi:10.2147/NDT.S225643 Galderisi, S., Mucci, ...
https://doi.org/10.2147/NDT.S225643 SEMINAR ON SCHIZOPHRENIA. SUBMITTED BY, SUBMITTED TO, MS. MARY CATHERIN D E. PROF. PRABAVATHY S II YEAR HEAD OF THE ...
https://doi.org/10.2147/ndt.s225643. Dong, M., Lu, L., Zhang, L., Zhang, Y.-S., Ng, C. H., Ungvari, G. S., Li, G., Meng, X., Wang,. G., & Xiang, Y.-T. (2019) ...
doi:10.2147/NDT.S225643 59. Helfer B, Samara MT, Huhn M, et al. Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a ...
doi:10.2147/NDT.S225643. Csoka, A.B., and Szyf, M. 2009. Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and ...
doi:10.2147/NDT.S225643. NatMed. Glycine. In: NatMed. NatMed; 2023. McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in ...
Neuropsychiatr Dis Treat 2020; 21; 16: 519–534. DOI: 10.2147/NDT.S225643. 5. Csehi R, Dombi ZB, Sebe B, Molnár MJ. Real-Life Clinical Experience ...
doi:10.2147/NDT.S225643. 4. Kadakia A, Catillon M, Fan Q, et al. The Economic Burden of Schizophrenia in the United States. J Clin Psychiatry ...
... 10.2147/NDT.S225643 7. Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms ...
... 10.2147/NDT.S225643 7. Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms ...
doi:10.2147/NDT.S225643. Cleveland Clinic. Antipsychotic Medications. https://my.clevelandclinic.org/health/treatments/24692-antipsychotic ...
doi:10.2147/NDT.S225643. Cleveland Clinic. Antipsychotic Medications. https://my.clevelandclinic.org/health/treatments/24692-antipsychotic ...
doi:10.2147/NDT.S225643; Fischer BA, Buchanan RW. Schizophrenia in Adults: Clinical Manifestations, Course, Assessment, and Diagnosis ...
... 10.2147/NDT.S225643. Contacts. Investor Daniel Busby ir@clicktherapeutics.com. Media Jonni Mills pr@clicktherapeutics.com. Susan Holz susan.holz ...
doi: 10.2147/NDT.S225643. PMID: 32110026; PMCID: PMC7041437. Kilian S, Asmal L, Goosen A, Chiliza B, Phahladira L, Emsley R. Instruments ...
doi: 10.2147/NDT.S225643. PMID: 32110026; PMCID: PMC7041437. Kilian S, Asmal L, Goosen A, Chiliza B, Phahladira L, Emsley R. Instruments ...